Health-related quality-of-life results from the randomised phase II TAVAREC trial on temozolomide with or without bevacizumab in 1p/19q intact first-recurrence World Health Organization grade 2 and 3 glioma (European Organization for Research and Treatment of Cancer 26091)Jaap C. Reijneveld, Martin J. van den Bent, Corneel Coens et al.|European Journal of Cancer|2023Cited by 13